Target intelligence / Profile preview

Dermatophagoides siboney allergens (D. siboney allergens)

Target
D. siboney allergens
Molecular classification
Allergen, Enzyme, Cysteine protease, Serine protease, Lipid-binding protein, Tropomyosin
01

Overview

Dermatophagoides siboney allergens are a complex group of proteins produced by the house dust mite species D. siboney, which is a major source of indoor allergens in tropical and subtropical regions, particularly Cuba (Ferrándiz et al., 1996, PMID: 8952544). These allergens include several well-characterized proteins such as Der s 1 (a cysteine protease), Der s 2 (a lipid-binding protein of the NPC2 family), and Der s 3 (a serine protease), which are officially recognized by the WHO/IUIS Allergen Nomenclature Sub-Committee. In sensitized individuals, these proteins act as antigens that cross-link IgE on the surface of mast cells and basophils, triggering the release of inflammatory mediators that lead to allergic asthma, rhinitis, and atopic dermatitis. From a therapeutic perspective, these allergens are the primary components of allergen-specific immunotherapy (AIT) products, such as the VALERGEN-DS extract, which are designed to desensitize the immune system through controlled exposure (Borroto et al., 2003, PMID: 12846871). Understanding the molecular composition of these allergens is essential for the development of standardized diagnostic tools and effective vaccines tailored to regional mite populations.

Other names
Cuban house dust mite allergensDer s allergensDermatophagoides siboney mite allergens
02

Mechanism of action

Allergen-specific immunotherapy (AIT) utilizes these allergens to induce immunological tolerance by shifting the immune response from a Th2-dominated profile to a Th1/Treg profile, increasing the production of blocking antibodies such as IgG4 and reducing IgE-mediated mast cell degranulation (Borroto et al., 2003, PMID: 12846871).

03

Biological functions

Immune responseProteolysisLipid transportMuscle contractionDigestion
04

Disease associations

Allergic asthmaAllergic rhinitisAtopic dermatitisType I hypersensitivity
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsAsthma exacerbation
06

Interacting drugs

Dermatophagoides siboney allergen extract

3 more in the full profile.

07

Biomarkers

Specific IgE (sIgE)Specific IgG4 (sIgG4)Skin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Dermatophagoides siboney allergens (D. siboney allergens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermatophagoides siboney allergens (D. siboney allergens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call